KGI Bldg. 535, Room 152

Join us as PhD in Applied Life Sciences student Andrew Burns speaks about a novel low shear 3D bioreactor for the scaled production of high purity human mesenchymal stem cells. "Human mesenchymal stem cells (hMSCs) are an ideal candidate for stem cell therapies. They have been widely researched since the 1960’s and can differentiate into many desired functional cell types without undergoing teratogenesis. Yet in order to develop a successful and marketable stem cell therapy, higher yields must be produced. It…